Principal Investigator: Baum, Linda

Sponsor Name: Mizutani Foundation for Glycoscience (Japan)

Award Title: Galectin-1 Regulates Migration of Dendritic Cells Across Lymphatic Endothelium

Principal Investigator: Belldegrun, Arie

Sponsor Name: Dendreon Corporation

Award Title: Registry of Sipuleucel-T therapy in Men with Advanced Prostate Cancer 

Principal Investigator: Brown, E. R.

Sponsor Name: Ca/California Children and Families Commission

Award Title: California Health Interview Survey (Chis) 2011-2012

Principal Investigator: Fielding, Jonathan

Sponsor Name: Robert Wood Johnson Foundation

Award Title: Health Impact Assessment (Hia) of State Tax Alternative: Demonstration, Outreach And Training To Increase Understanding of Hia Among State Policy Anal

Principal Investigator: Finn, Richard

Sponsor Name: Roche Laboratories, Inc.

Award Title: UCLA: Roche Collaboration - A Preclinical Research Program to Evaluate Potential Translational Science for the Glypican-3 Monoclonal Antibody Gc-33, Pdk-1, And Ptk-2

Principal Investigator: Goldman, Jonathan

Sponsor Name: Clovis Oncology

Award Title: Phase 1/2, Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral CO-1686 in Patients With Previously Treated Mutant EGFR Non-Small Cell Lung Cancer (NSCLC)

Principal Investigator: Hurvitz, Sara

Sponsor Name: Eisai America, Inc.

Award Title: Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Positive Breast Cancer 

Principal Investigator: Maynard, Heather

Sponsor Name: Burroughs Wellcome Fund

Award Title: Nanopatterning Proteins for Enhancement of Bone Cell Adhesion 

Principal Investigator: Pietras, Richard J

Sponsor Name: Eisai America, Inc.

Award Title: Gateway for Cancer Research

Principal Investigator: Ritz, Beate

Sponsor Name: NIH/National Institute of Environmental Health Sciences

Award Title: "Parental Occupation and Childhood Cancers"

Principal Investigator: Schiller, Gary

Sponsor Name: Talon Therapeutics

Award Title: Phase 3, Multicenter, Randomized Study to Evaluate the Substitution of Marqibo (Vincristine Sulfate Liposomes Injection, VSLI) for Standard Vincristine Sulfate Injection (VSI) in The Induction, Intensification, and Maintenance Phases of Combination Chemotherapy in the Treatment of Subjects > 60 Years Old with Newly Disagnosed Acute Lymphoblastic Leukemia 

Principal Investigator: Wong, Steven

Sponsor Name: Pharmaceutical Research Associates, Inc. 

Award Title: Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma